These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 23918357)
1. Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies. Sánchez-Martín D; Martínez-Torrecuadrada J; Teesalu T; Sugahara KN; Alvarez-Cienfuegos A; Ximénez-Embún P; Fernández-Periáñez R; Martín MT; Molina-Privado I; Ruppen-Cañás I; Blanco-Toribio A; Cañamero M; Cuesta AM; Compte M; Kremer L; Bellas C; Alonso-Camino V; Guijarro-Muñoz I; Sanz L; Ruoslahti E; Alvarez-Vallina L Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13791-6. PubMed ID: 23918357 [TBL] [Abstract][Full Text] [Related]
2. Intravenous infusion of phage-displayed antibody library in human cancer patients: enrichment and cancer-specificity of tumor-homing phage-antibodies. Shukla GS; Krag DN; Peletskaya EN; Pero SC; Sun YJ; Carman CL; McCahill LE; Roland TA Cancer Immunol Immunother; 2013 Aug; 62(8):1397-410. PubMed ID: 23736951 [TBL] [Abstract][Full Text] [Related]
3. Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer. Liu B; Conrad F; Roth A; Drummond DC; Simko JP; Marks JD J Mol Med (Berl); 2007 Oct; 85(10):1113-23. PubMed ID: 17554518 [TBL] [Abstract][Full Text] [Related]
4. Phage display-based on-slide selection of tumor-specific antibodies on formalin-fixed paraffin-embedded human tissue biopsies. Ten Haaf A; Pscherer S; Fries K; Barth S; Gattenlöhner S; Tur MK Immunol Lett; 2015 Aug; 166(2):65-78. PubMed ID: 26045318 [TBL] [Abstract][Full Text] [Related]
5. Discovery of internalizing antibodies to tumor antigens from phage libraries. Zhou Y; Marks JD Methods Enzymol; 2012; 502():43-66. PubMed ID: 22208981 [TBL] [Abstract][Full Text] [Related]
7. Identification of target and function specific antibodies for effective drug delivery. Zhou Y; Marks JD Methods Mol Biol; 2009; 525():145-60, xv. PubMed ID: 19252832 [TBL] [Abstract][Full Text] [Related]
8. Parallel evaluation of cell‑based phage display panning strategies: Optimized selection and depletion steps result in AML blast‑binding consensus antibodies. Weber T; Pscherer S; Gamerdinger U; Teigler-Schlegel A; Rutz N; Blau W; Rummel M; Gattenlöhner S; Tur MK Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34490477 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery. Romani C; Cocco E; Bignotti E; Moratto D; Bugatti A; Todeschini P; Bandiera E; Tassi R; Zanotti L; Pecorelli S; Sartori E; Odicino FE; de Marco A; Santin AD; Ravaggi A; Mitola S Oncotarget; 2015 Oct; 6(33):34617-28. PubMed ID: 26416446 [TBL] [Abstract][Full Text] [Related]
10. High-content analysis of antibody phage-display library selection outputs identifies tumor selective macropinocytosis-dependent rapidly internalizing antibodies. Ha KD; Bidlingmaier SM; Zhang Y; Su Y; Liu B Mol Cell Proteomics; 2014 Dec; 13(12):3320-31. PubMed ID: 25149096 [TBL] [Abstract][Full Text] [Related]
11. Abnormally high expression of proteasome activator-gamma in thyroid neoplasm. Okamura T; Taniguchi S; Ohkura T; Yoshida A; Shimizu H; Sakai M; Maeta H; Fukui H; Ueta Y; Hisatome I; Shigemasa C J Clin Endocrinol Metab; 2003 Mar; 88(3):1374-83. PubMed ID: 12629132 [TBL] [Abstract][Full Text] [Related]
12. The proteasome subunit, C2, contains an important site for binding of the PA28 (11S) activator. Kania MA; Demartino GN; Baumeister W; Goldberg AL Eur J Biochem; 1996 Mar; 236(2):510-6. PubMed ID: 8612623 [TBL] [Abstract][Full Text] [Related]
13. Nucleotide sequence analysis of the approximately 35-kb segment containing interferon-gamma-inducible mouse proteasome activator genes. Yawata M; Murata S; Tanaka K; Ishigatsubo Y; Kasahara M Immunogenetics; 2001 Mar; 53(2):119-29. PubMed ID: 11345588 [TBL] [Abstract][Full Text] [Related]
15. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen. Huang X; Bennett M; Thorpe PE Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089 [TBL] [Abstract][Full Text] [Related]
16. Selection of scFv Antibody Fragments Binding to Human Blood versus Lymphatic Endothelial Surface Antigens by Direct Cell Phage Display. Keller T; Kalt R; Raab I; Schachner H; Mayrhofer C; Kerjaschki D; Hantusch B PLoS One; 2015; 10(5):e0127169. PubMed ID: 25993332 [TBL] [Abstract][Full Text] [Related]
17. Selection of a breast cancer subpopulation-specific antibody using phage display on tissue sections. Larsen SA; Meldgaard T; Fridriksdottir AJ; Lykkemark S; Poulsen PC; Overgaard LF; Petersen HB; Petersen OW; Kristensen P Immunol Res; 2015 Jul; 62(3):263-72. PubMed ID: 25963139 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the proteasome activator PA28 is required for proteasome activation. Li N; Lerea KM; Etlinger JD Biochem Biophys Res Commun; 1996 Aug; 225(3):855-60. PubMed ID: 8780702 [TBL] [Abstract][Full Text] [Related]
19. Selection of tumor-specific internalizing human antibodies from phage libraries. Poul MA; Becerril B; Nielsen UB; Morisson P; Marks JD J Mol Biol; 2000 Sep; 301(5):1149-61. PubMed ID: 10966812 [TBL] [Abstract][Full Text] [Related]
20. Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody. Hao CH; Han QH; Shan ZJ; Hu JT; Zhang N; Zhang XP Theor Biol Med Model; 2015 Aug; 12():14. PubMed ID: 26246000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]